205 related articles for article (PubMed ID: 37894317)
1. Comprehensive Analysis of DNA Methyltransferases Expression in Primary and Relapsed Ovarian Carcinoma.
Papakonstantinou E; Pappa I; Androutsopoulos G; Adonakis G; Maroulis I; Tzelepi V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894317
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression.
Tzelepi V; Logotheti S; Efstathiou E; Troncoso P; Aparicio A; Sakellakis M; Hoang A; Perimenis P; Melachrinou M; Logothetis C; Zolota V
Pathology; 2020 Feb; 52(2):218-227. PubMed ID: 31864524
[TBL] [Abstract][Full Text] [Related]
4. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
5. Expression of DNMTs and MBD2 in GIST.
He M; Fan J; Jiang R; Tang WX; Wang ZW
Biomed Rep; 2013 Mar; 1(2):223-227. PubMed ID: 24648923
[TBL] [Abstract][Full Text] [Related]
6. DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy.
Man X; Li Q; Wang B; Zhang H; Zhang S; Li Z
Front Cell Dev Biol; 2022; 10():916725. PubMed ID: 35620052
[TBL] [Abstract][Full Text] [Related]
7. DNMT1, DNMT3A and DNMT3B proteins are differently expressed in mouse oocytes and early embryos.
Uysal F; Ozturk S; Akkoyunlu G
J Mol Histol; 2017 Dec; 48(5-6):417-426. PubMed ID: 29027601
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues.
Gu Y; Yang P; Shao Q; Liu X; Xia S; Zhang M; Xu H; Shao Q
Oncol Lett; 2013 Feb; 5(2):452-458. PubMed ID: 23420051
[TBL] [Abstract][Full Text] [Related]
9. Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas.
Nagai M; Nakamura A; Makino R; Mitamura K
Hepatol Res; 2003 Jul; 26(3):186-191. PubMed ID: 12850690
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.
Supic G; Kozomara R; Zeljic K; Jovic N; Magic Z
Clin Oral Investig; 2017 Jan; 21(1):173-182. PubMed ID: 26966018
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
13. Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China.
Sun MY; Yang XX; Xu WW; Yao GY; Pan HZ; Li M
Genet Mol Res; 2012 Dec; 11(4):4330-41. PubMed ID: 23079992
[TBL] [Abstract][Full Text] [Related]
14. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
J Cell Physiol; 2018 Sep; 233(9):7305-7319. PubMed ID: 29574992
[TBL] [Abstract][Full Text] [Related]
15. Molecular enzymology of mammalian DNA methyltransferases.
Jeltsch A
Curr Top Microbiol Immunol; 2006; 301():203-25. PubMed ID: 16570849
[TBL] [Abstract][Full Text] [Related]
16. Correlative Analysis of DNA Methyltransferase Expression and Promoter Hypermethylation of Tumor Suppressor Genes in Hepatocellular Carcinoma.
Lam TW; Tong JH; To KF; Chan A; Liew CT; Lai PB; Wong N
Cancer Genomics Proteomics; 2006; 3(3-4):271-277. PubMed ID: 31394707
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection in hepatocellular carcinoma tissues upregulates expression of DNA methyltransferases.
Li H; Yang F; Gao B; Yu Z; Liu X; Xie F; Zhang J
Int J Clin Exp Med; 2015; 8(3):4175-85. PubMed ID: 26064328
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the impact of DNA methylation machinery: Dnmt1 and Dnmt3a in orchestrating oocyte development and cellular homeostasis.
Uysal F; Sukur G; Bozdemir N; Cinar O
Genesis; 2024 Feb; 62(1):e23579. PubMed ID: 37985411
[TBL] [Abstract][Full Text] [Related]
19. The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
J Ovarian Res; 2023 Jun; 16(1):124. PubMed ID: 37386587
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism in DNMTs and gastric cancer: A systematic review and meta-analysis.
Neves M; Ribeiro J; Medeiros R; Sousa H
Porto Biomed J; 2016; 1(5):164-172. PubMed ID: 32258570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
